Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial
<p><b>Background</b></p> The serotonin 4 receptor (5-HT4R) is a promising target for the treatment of depression. Highly selective 5-HT4R agonists, such as prucalopride, have antidepressant-like and procognitive effects in preclinical models, but their clinical effects are no...
Asıl Yazarlar: | , , , , , , , |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Cambridge University Press
2024
|